Navidea Biopharmaceuticals (NAVB) Stock Chart & Stock Price History $0.0007 0.00 (0.00%) As of 06/13/2025 01:46 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Navidea Biopharmaceuticals Stock Price Performance The Navidea Biopharmaceuticals (NAVB) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 600.00%. In the past month, the stock has decreased 93.00%, reflecting recent market activity. As of the latest close, Navidea Biopharmaceuticals traded at $0.00 with a market cap of $70 thousand and volume of 3,361 shares. Five years ago, the stock traded at $2.82, representing a 99.98% decrease over that period. At the time, it had a market cap of $61.04 million and a volume of 694,000 shares. Receive NAVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-93.00%3 Month Performance+600.00%Year-To-Date Performance+600.00%5 Year Performance-99.98% NAVB Stock Chart for Saturday, June, 14, 2025 NAVB Chart by TradingView Navidea Biopharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.00$0.00$0.00$0.003,361 shs$70,000.0006/12/2025$0.00$0.00$0.00$0.0010,524 shs$70,000.0006/11/2025$0.00$0.00$0.00$0.00306 shs$70,000.0006/10/2025$0.00$0.00$0.00$0.00852 shs$70,000.0006/09/2025$0.00$0.00$0.00$0.00228 shs$70,000.0006/06/2025$0.00$0.00$0.00$0.00527 shs$70,000.0006/05/2025$0.00$0.00$0.00$0.003,055 shs$70,000.0006/04/2025$0.00$0.00$0.00$0.003,055 shs$70,000.0006/03/2025$0.00$0.00$0.00$0.003,055 shs$70,000.0005/30/2025$0.00$0.00$0.00$0.004,000 shs$70,000.00 Get the Latest News and Ratings for NAVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$0.00$0.00-12.50%$0.00$0.004,000 shs$70,000.0005/28/2025$0.00$0.00+14.29%$0.00$0.00320 shs$80,000.0005/27/2025$0.00$0.00$0.00$0.00538 shs$70,000.0005/26/2025$0.00$0.00$0.00$0.00538 shs$70,000.0005/23/2025$0.00$0.00$0.00$0.00538 shs$70,000.0005/22/2025$0.00$0.00$0.00$0.00194 shs$70,000.0005/21/2025$0.00$0.00$0.00$0.00194 shs$70,000.0005/20/2025$0.00$0.00$0.00$0.00467 shs$70,000.0005/19/2025$0.00$0.00$0.00$0.00467 shs$70,000.0005/16/2025$0.00$0.00$0.00$0.00467 shs$70,000.0005/15/2025$0.01$0.00-93.00%$0.00$0.001,170 shs$70,000.0005/14/2025$0.01$0.01$0.01$0.00703 shs$1.00 million05/13/2025$0.01$0.01$0.01$0.00703 shs$1.00 million Related Companies TC Biopharm Stock Chart Bon Natural Life Stock Chart Vincerx Pharma Stock Chart Universe Pharmaceuticals Stock Chart Ampio Pharmaceuticals Stock Chart Smart for Life Stock Chart Scopus BioPharma Stock Chart Calithera Biosciences Stock Chart Evelo Biosciences Stock Chart Comera Life Sciences Stock Chart Receive NAVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NAVB) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
